Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Lignende værker

• Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
  af: Mease, Philip J.
  Udgivet: (2014)
• Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
  af: Kavanaugh, Arthur, et al.
  Udgivet: (2014)
• Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
  af: Mease, Philip, et al.
  Udgivet: (2016)
• Phosphodiesterase 4 inhibitors for psoriatic arthritis
  af: Zamora, Natalia V, et al.
  Udgivet: (2016)
• The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
  af: V. I. Mazurov, et al.
  Udgivet: (2018-04-01)